Goldman Sachs, Charles Schwab And This Healthcare Stock On CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades', Joshua Brown of Ritholtz Wealth Management named Biogen Inc. as the 4th cheapest stock in the Health Care Select Sector SPDR Fund XLV. Karen Firestone of Aureus Asset Management mentioned The Charles Schwab Corporation, which trades at 16 times next year’s earnings. Amy Raskin of Chevy Chase Trust named The Goldman Sachs Group, Inc. as her final trade. Goldman Sachs reported a 60% Y/Y plunge in second-quarter EPS, missing consensus.
July 21, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Charles Schwab Corporation trades at 16 times next year’s earnings and reported better-than-expected second-quarter financial results.
The positive mention of Charles Schwab's earnings multiple and better-than-expected results could lead to increased investor interest.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 70
NEUTRAL IMPACT
Biogen was named as the 4th cheapest stock in the Health Care Select Sector SPDR Fund XLV. The company is scheduled to report quarterly earnings next week.
The mention of Biogen as a cheap stock could attract investors, but the upcoming earnings report introduces uncertainty.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Goldman Sachs Group reported a 60% Y/Y plunge in second-quarter EPS, missing the consensus. However, the stock gained 3% to settle at $350.86.
Despite the stock's gain, the significant drop in Goldman Sachs' EPS and missed consensus could negatively impact investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80